Literature DB >> 6811175

The long-term management of hypertension with verapamil.

G R Lewis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6811175

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol Suppl        ISSN： 0143-9294


× No keyword cloud information.
  4 in total

1.  Risk factors in the management of the unique hypertensive patient.

Authors:  J T Wright
Journal:  J Natl Med Assoc       Date:  1987-03       Impact factor: 1.798

Review 2.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

3.  Metabolic parameters after changing from hydrochlorothiazide to verapamil treatment in hypertension.

Authors:  A Lehtonen; A Gordin
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Diltiazem and verapamil: functional antagonism of exogenous noradrenaline and angiotensin II in man.

Authors:  D Magometschnigg; H Hörtnagl; H Rameis
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.